ScholarWorks@Gachon: Kim, Yun Soo

Detailed Information

Kim, Yun Soo (김연수)

College of Medicine (Department of Medicine)

Research Area

Tel 032-460-3778
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Hepatocellular carcinoma:8||Ribavirin:6||hepatocellular carcinoma:6||Entecavir:5||Chronic hepatitis C:4||Chronic hepatitis B:4||Hepatitis B:3||Hepatitis B virus:3||IL28B:3||entecavir:2||Korea:2||Korean:2||Sustained virological response:2||Lamivudine:2||Liver:2||Adefovir:2||Peginterferon:2||Pegylated interferon alfa2a:2||Liver fibrosis:2||Pegylated interferon alfa2b:2||Prevalence:2||Prognosis:2||Magnetic resonance imaging:2||Rac1:2||Resistance:2||Contrastenhanced ultrasound:2||Hepatitis C:2||Sorafenib:2||Esophageal and gastric varices:1||Fibrosis:1||Functional cure:1||Gallbladder:1||Gastrointestinal cancer:1||Gene signature:1||Genotype 6:1||Glomerular Filtration Rate:1||Granular cell tumor:1||Guideline:1||HBsAg loss:1||HBsAg reversion:1||HCV RNA:1||Hemorrhage:1||Hepatic fibrosis:1||Hepatic resection:1||Hepatitis B Core Antigen:1||Hepatitis B Virus:1||Hepatitis B core:1||Hepatitis C Virus:1||Hepatitis C virus:1||Hepatitis C, Chronic:1||Hepatocellular:1||Hepatocellular carcinoma (HCC):1||Hypoxia:1||Hypoxiainducible factor1 alpha (HIF1 alpha):1||ITPA:1||Liver abscess:1||Liver cirrhosis:1||Liver stiffness:1||Lymphoma:1||Matrix metalloproteinase 2:1||Matrix metalloproteinase 9:1||Metabolic syndrome:1||Metastasis:1||Muscular diseases:1||NADPH oxidase:1||Neurilemmoma:1||Nonalcoholic fatty liver disease:1||Nonalcoholic fatty liver disease:1||Nucleos(t)ide analogues:1||Occult hepatitis B virus infection:1||Partial virological response:1||Pegylated interferon alpha:1||Peripheral nervous system neoplasms:1||Pooled analysis:1||Proteinuria:1||Pseudolymphoma:1||Resolution:1||Rifaximin:1||Risk factor:1||Risk factors:1||Snail:1||Spontaneous:1||Sustained Virologic Response:1||T2weighted imaging:1||TIPS:1||Tenofovir:1||Toxocariasis:1||Transcatheter arterial chemoembolization (TACE):1||Transient elastography:1||Treatment failure:1||Treatment outcome:1||Treatment response:1||Vaccination:1||Vascular invasion:1||Vertical infection transmission:1||Visceral larva migrans:1||adefovir:1||antiviral therapy:1||artificial intelligence:1||chemoembolization:1||chronic hepatitis B:1||cirrhosis:1||contrastenhanced CT:1||contrastenhanced ultrasound:1||diffusionweighted magnetic resonance imaging:1||dysplastic nodule:1||epithelialmesenchymal transition:1||gene polymorphism:1||guiding technique:1||hepatitis B virus:1||hepatitis C virus:1||histological grade:1||intrahepatic cholangiocarcinoma:1||lamivudine:1||liver fibrosis:1||liver function:1||microvascular invasion:1||overall survival:1||p21activated kinases 1:1||peritumoral decreased uptake area:1||radiofrequency ablation:1||radiomics:1||refractory ascites:1||resistance:1||treatment response:1||tumor recurrence:1||간세포암:1||근육병증:1||대사 증후군:1||리바비린:1||림프종:1||만성C형간염:1||비알코올 지방간 질환:1||엔테카비어:1||원인 미상:1||위험인자:1||유병률:1||유전자 6형:1||치료반응:1||클레부딘:1||통합분석:1||페그인터페론:1||항암제:1||8hydroxydeoxyguanosine:1||핵심항원:1||Alanine aminotransferase:1||Alcoholic cirrhosis:1||Anemia:1||AntiHCV:1||Antiviral agents:1||Antiviral treatment:1||Asunaprevir:1||Bile duct ligation:1||Biliary tract:1||Biomarker:1||B형 간염:1||B형간염:1||Carcinoma:1||Casecontrol study:1||Chemotherapy:1||Chronic Renal Insufficiency:1||Cirrhosis:1||Clevudine:1||Cryptogenic:1||Cysts:1||C형간염:1||Daclatasvir:1||Dapsone therapy:1||Drug resistance:1||Dysplastic nodule:1||Elasticity imaging techniques:1||Epidemiology:1||

STATISTICS: Total View :4,136,558; Today View :4,237

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE